Overview
Lobbying Costs
17,500€
Financial year: Jan 2018 - Dec 2018
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Norgine B.V.
EU Transparency Register
117307619414-45 First registered on 09 Nov 2015
Goals / Remit
Norgine B.V. is a European specialist pharma company which develops, manufactures and commercialises specialist products in the EU.
Main EU files targeted
We follow EU initiatives, policies and legislation relating to the pharmaceutical industry and those specific to the therapy areas we work in such as gastroenterology as well as the impact of BREXIT on our business.
Address
Head Office
Antonio Vivaldistraat 150
Amsterdam 1083 HP
NETHERLANDSEU Office
Norgine NV/SA
Haasrode Research Park
Heverlee 3001
BELGIUM -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Mr Peter Martin (COO)
Person with legal responsibility
Mr Peter Stein (CEO)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
http://www.eucope.org/en/
www.efpia.eu
European Medicines Group
https://www.abpi.org.uk/Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2018 - Dec 2018
Lobbying costs for closed financial year
17,500€
Other financial info
n/a
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
Participation on events organised by trade bodies and in meetings with individual members of the European Parliament.
Organisation of a roundtable in the European Parliament arranged collaboratively between Norgine and a patient group and individual members of the European Parliament to ignite discussions on improving colonoscopy services.Other activities
Norgine 's activities are led by Decideum Ltd and Incisive Health
- Meetings
Meetings
None declared
- Meetings